Table 4.
Overall Survival |
Local Control |
||||
---|---|---|---|---|---|
Factor | Univariate | Multivariate | Factor | Univariate | Multivariate |
Systemic therapy post-SBRT | P = .0209 | P = .0246/HR = 2.338 (95% CI, 1.115–4.903) | 18–26 Gy/1–2 fractions vs 18–40 Gy/3–5 fractions | P = .0292 | P = .0224;/HR = 0.322 (95% CI, 0.122–0.852) |
Preoperative Bilsky grade | P = .0956 | NS | Postoperative Bilsky grade 0/1 vs 2/3 | P = .0092 | P = .003;/HR = 0.225 (95% CI, 0.084–0.604) |
18–26 Gy in 1–2 fractions vs 18–40 Gy in 3–5 fractions | P = .09 | NS | CTV V80 | P = .0914 | NS |
Presence of lung and liver metastases | P = .0715 | NS | Systemic therapy post-SBRT | P = .1012 | NS |
Abbreviations: NS, not significant; CTV V80, volume of the clinical target volume encompassed by 80% of the prescribed dose.
Only those factors with P≤ .1 are shown for the univariate analysis and only those significant at P≤ .05 are shown for the multivariate analysis.